首页> 外文期刊>Hormone and Metabolic Research >Risk of Thyroid Disorders in Patients with Gout and Hyperuricemia
【24h】

Risk of Thyroid Disorders in Patients with Gout and Hyperuricemia

机译:痛风和高尿酸血症患者甲状腺疾病的风险

获取原文
获取原文并翻译 | 示例
           

摘要

The risk of thyroid autoimmunity and thyroid dysfunction among patients with gout and hyperuricemia has not been well defined. This study was undertaken to examine the impact of gout and hyperuricemia on risk of thyroid disorders including thyroid autoimmunity and thyroid dysfunction. A population-based cross-sectional study was conducted to assess the risk of thyroid autoimmunity and thyroid dysfunction related to gout and hyperuricemia, which included 115 gout patients, 439 hyperuricemic patients, and 2 254 individuals without gout and hyperuricemia. A systematic review and meta-analysis of 14 observational studies was also done to systematically evaluate the risk of thyroid dysfunction among patients with gout and hyperuricemia. Findings from the cross-sectional study suggested a significantly increased risk of hypothyroidism among female gout patients (OR=2.44, 95% CI 1.15-5.17, p=0.02). Besides, gout could also substantially increase risk of Hashimoto's thyroiditis in women (OR=3.15, 95% CI 1.53-6.49, p=0.002). The meta-analysis proved a considerably increased risk of hypothyroidism among both gout patients (OR=1.51, 95% CI 1.23-1.85, p<0.001) and hyperuricemic patients (OR=1.34, 95% CI 1.11-1.61, p=0.002). Moreover, this meta-analysis also suggested that gout could also significantly increase the risk of hyperthyroidism (OR=1.25, 95% CI 1.06-1.48, p=0.01). The findings from the study suggest increasing risk of hypothyroidism and Hashimoto's thyroiditis among gout patients. Moreover, gout but not hyperuricemia is linked to increased risk of hyperthyroidism. More studies are warranted to elucidate the influence of gout and hyperuricemia on thyroid disorders.
机译:痛风和高尿酸血症患者的甲状腺自身免疫和甲状腺功能障碍的风险尚未明确。本研究旨在检验痛风和高尿酸血症对甲状腺疾病风险的影响,包括甲状腺自身免疫和甲状腺功能障碍。进行了一种基于人群的横截面研究,以评估甲状腺自身免疫和甲状腺功能障碍的风险,与痛风和高尿血症相关,其中包括115名痛风患者,439名高尿酸患者,2254名没有痛风和高尿酸血症。还进行了14项观测研究的系统评价和荟萃分析,以系统地评估痛风和高尿酸血症患者甲状腺功能障碍的风险。横截面研究的结果表明女性痛风患者甲状腺功能减退的风险显着增加(或= 2.44,95%CI 1.15-5-5.17,P = 0.02)。此外,痛风还可以大大增加血小板甲状腺炎的风险(或= 3.15,95%CI 1.53-6.49,P = 0.002)。 Meta分析证明了痛风患者(OR = 1.51,95%CI 1.85,P <0.001)和高尿动患者(或= 1.34,95%CI 1.11-1.61,P = 0.002)的大大增加的甲状腺功能减退症的风险。此外,这种META分析还表明痛风也可以显着增加甲状腺功能亢进的风险(或= 1.25,95%CI 1.06-1.48,P = 0.01)。研究结果表明,呼出患者中甲状腺功能减退症和Hashimoto的甲状腺炎的风险增加。此外,痛风但不高发性血症与甲状腺功能亢进的风险增加有关。有必要进行更多的研究来阐明痛风和高尿酸对甲状腺疾病的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号